Long-term Extension of a Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Efficacy, andTolerability of Multiple Subcutaneous Doses of rAvPALPEGin Subjects with PKU

Biotechnology Computer Science Energy Engineering Environmental Sciences Information Science Life Sciences Mathematics Medical Sciences

Military Sciences Natural Sciences Physical Sciences Plant Sciences Science Space Sciences Technology Transportation